Alpha DNA Investment Management’s Allstate ALL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,829
Closed -$816K 198
2023
Q4
$816K Buy
+5,829
New +$760K 0.32% 62
2021
Q2
Sell
-3
Closed 124
2021
Q1
$0 Hold
3
﹤0.01% 678
2020
Q4
$0 Buy
+3
New +$295 ﹤0.01% 582

Other funds holding ALL

Alpha DNA Investment Management's ALL Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of Allstate (ALL) in Q1 2024, closing a stake of 5,829 shares — an estimated $816K sold.

Alpha DNA Investment Management first reported a position in ALL in Q4 2020 and held it in 3 quarters. The position peaked at $816K in Q4 2023. 1,326 funds tracked by Wall St. Rank hold ALL as of Q1 2024.

  • Alpha DNA Investment Management reported no remaining Allstate position as of Q1 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 5,829 Allstate shares in Q1 2024, an estimated $816K.
  • Alpha DNA Investment Management first reported a position in Allstate in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Allstate position peaked at $816K in Q4 2023.
  • 1,326 funds tracked by Wall St. Rank held Allstate as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.